DAROLUTAMIDE for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 6 adverse event reports in the FDA FAERS database where DAROLUTAMIDE was used for Neoplasm malignant.
Most Reported Side Effects for DAROLUTAMIDE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Fatigue | 384 | 11.8% | 11 | 62 |
| Death | 361 | 11.1% | 359 | 23 |
| Hot flush | 203 | 6.3% | 4 | 26 |
| Asthenia | 173 | 5.3% | 8 | 49 |
| Prostatic specific antigen increased | 156 | 4.8% | 9 | 23 |
| Off label use | 133 | 4.1% | 10 | 30 |
| Neuropathy peripheral | 127 | 3.9% | 0 | 12 |
| Diarrhoea | 122 | 3.8% | 4 | 25 |
| Dizziness | 122 | 3.8% | 3 | 28 |
| Rash | 116 | 3.6% | 5 | 17 |
| Arthralgia | 115 | 3.5% | 3 | 22 |
| Nausea | 111 | 3.4% | 1 | 32 |
| Dyspnoea | 109 | 3.4% | 8 | 41 |
| Pain in extremity | 106 | 3.3% | 4 | 32 |
| Decreased appetite | 105 | 3.2% | 7 | 34 |
Other Indications for DAROLUTAMIDE
Prostate cancer (990)
Hormone-refractory prostate cancer (553)
Hormone-dependent prostate cancer (294)
Prostate cancer metastatic (200)
Product used for unknown indication (193)
Metastases to bone (31)
Metastasis (18)
Metastases to lymph nodes (11)
Metastases to lung (9)
Prostate cancer stage iv (8)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)